Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dorr

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acidRoss O Meyers, Joshua D Lambert, Nicole Hajicek, et al.
Cancer Research|September 15, 1988
In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein ratiosR T Dorr, K A Bozak, N G Shipp, et al.
Cancer Chemotherapy and Pharmacology|August 14, 1999
Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesiaA M Lopez, L Wallace, R T Dorr, et al.
Journal of the National Cancer Institute|November 1, 1983
A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasiaF L Meyskens, V Graham, M Chvapil, et al.
Molecular Cancer Research : MCR|January 26, 2012
Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cellsElena V Sheveleva, Terry H Landowski, Betty K Samulitis, et al.
Toxicon : Official Journal of the International Society on Toxinology|November 30, 2002
Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouseJoshua D Lambert, Dedun Zhao, Ross O Meyers, et al.
Journal of Medicinal Chemistry|November 26, 1997
1,4-disubstituted anthracene antitumor agentsB S Iyengar, R T Dorr, D S Alberts, et al.
Journal of the National Cancer Institute|August 19, 1992
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitroE M Hersh, C R Gschwind, C W Taylor, et al.
Anti-Cancer Drugs|November 20, 2002
Imexon activates an intrinsic apoptosis pathway in RPMI8226 myeloma cellsKaterina Dvorakova, Claire M Payne, Terry H Landowski, et al.
Life Sciences|January 1, 1996
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyR T Dorr, R Lines, N Levine, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acidRoss O Meyers, Joshua D Lambert, Nicole Hajicek, et al.
Cancer Research|September 15, 1988
In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein ratiosR T Dorr, K A Bozak, N G Shipp, et al.
Cancer Chemotherapy and Pharmacology|August 14, 1999
Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesiaA M Lopez, L Wallace, R T Dorr, et al.
Journal of the National Cancer Institute|November 1, 1983
A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasiaF L Meyskens, V Graham, M Chvapil, et al.
Molecular Cancer Research : MCR|January 26, 2012
Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cellsElena V Sheveleva, Terry H Landowski, Betty K Samulitis, et al.
Toxicon : Official Journal of the International Society on Toxinology|November 30, 2002
Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouseJoshua D Lambert, Dedun Zhao, Ross O Meyers, et al.
Journal of Medicinal Chemistry|November 26, 1997
1,4-disubstituted anthracene antitumor agentsB S Iyengar, R T Dorr, D S Alberts, et al.
Journal of the National Cancer Institute|August 19, 1992
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitroE M Hersh, C R Gschwind, C W Taylor, et al.
Anti-Cancer Drugs|November 20, 2002
Imexon activates an intrinsic apoptosis pathway in RPMI8226 myeloma cellsKaterina Dvorakova, Claire M Payne, Terry H Landowski, et al.
Life Sciences|January 1, 1996
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyR T Dorr, R Lines, N Levine, et al.
Pageof 19